ASSESSMENT OF THE EFFICACY AND SAFETY OF FLUTIFORM® PMDI 125/5 ΜG (2 PUFFS BID) VERSUS SYMBICORT® TURBOHALER® 200/6 ΜG (2 PUFFS BID) IN ADOLESCENT AND ADULT SUBJECTS WITH MODERATE TO SEVERE PERSISTENT, REVERSIBLE ASTHMA: